P. Vejvisithsakul

EMP2 induces cytostasis and apoptosis via the TGFβ/SMAD/SP1 axis and recruitment of P2RX7 in urinary bladder urothelial carcinoma

Szu-Yu Chen, Y. Hsu, Cheng-Tang Pan, 2021, Cellular Oncology.

A STING antagonist modulating the interaction with STIM1 blocks ER-to-Golgi trafficking and inhibits lupus pathology

F. Pedersen, T. Pisitkun, S. Paludan, 2021, EBioMedicine.

Role of STING/TMEM173

Søren Riis, T. Pisitkun, S. Paludan, 2022 .

Development of ultra-short PCR assay to reveal BRAF V600 mutation status in Thai colorectal cancer tissues

S. Shuangshoti, P. Vejvisithsakul, C. Teerapakpinyo, 2018, PloS one.

The autocrine glycosylated-GREM1 interacts with TGFB1 to suppress TGFβ/BMP/SMAD-mediated EMT partially by inhibiting MYL9 transactivation in urinary carcinoma

Cheng-Tang Pan, T. Chan, Wen-Jeng Wu, 2023, Cellular Oncology.

BRAF mutation in cytologically indeterminate thyroid nodules: after reclassification of a variant thyroid carcinoma

C. Chongkolwatana, P. Vejvisithsakul, N. Poungvarin, 2019, OncoTargets and therapy.

Aptamer/doxorubicin-conjugated nanoparticles target membranous CEMIP2 in colorectal cancer.

Cheng-Tang Pan, Chien-Feng Li, Y. Shiue, 2023, International journal of biological macromolecules.